Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals

Slični predmeti

• Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients
  od: Holman, R, i dr.
  Izdano: (1996)
• Effects of ethnicity on metabolic control during the first six years of NIDDM
  od: Davis, T, i dr.
  Izdano: (1997)
• Insulin use in NIDDM. Rationale based on pathophysiology of disease.
  od: Turner, R, i dr.
  Izdano: (1990)
• No glycemic benefit from guar administration in NIDDM.
  od: Holman, R, i dr.
  Izdano: (1987)
• Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients
  od: Stratton, I, i dr.
  Izdano: (1996)